The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030,
The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade.
It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: Key companies covered in the report: For more information, please click on the following link: https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html Other recent offerings About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.
The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at
[email protected] Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415
[email protected] Source: Free Articles from ArticlesFactory.com .